Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
$2.04
+11.8%
$2.80
$1.81
$8.31
$25.36M2.15152,129 shs269,109 shs
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
$0.00
$0.00
$0.07
$6.39M-0.068,998 shsN/A
MMTec, Inc. stock logo
MTC
MMTec
$0.92
+5.0%
$1.01
$0.76
$6.42
$23.00M0.3107,875 shs36,346 shs
Semantix, Inc. stock logo
STIX
Semantix
$0.00
$0.28
$4.77
$23.73M-0.3752,087 shsN/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
0.00%-21.89%-22.88%-36.81%+181,999,900.00%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
0.00%0.00%0.00%-98.00%0.00%
MMTec, Inc. stock logo
MTC
MMTec
0.00%-7.75%-1.40%-11.11%-68.02%
Semantix, Inc. stock logo
STIX
Semantix
0.00%0.00%0.00%0.00%-99.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
N/AN/AN/AN/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
N/AN/AN/AN/AN/AN/AN/AN/A
Semantix, Inc. stock logo
STIX
Semantix
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
0.00
N/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
0.00
N/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
0.00
N/AN/AN/A
Semantix, Inc. stock logo
STIX
Semantix
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
$70.31M0.36N/AN/A($1.64) per share-1.24
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
$1.10M0.00N/AN/AN/ANaN
MMTec, Inc. stock logo
MTC
MMTec
$1.87M12.30N/AN/A$1.07 per share0.86
Semantix, Inc. stock logo
STIX
Semantix
$264.23M0.00N/AN/A$1.01 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
-$14.51MN/A0.00N/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/A-$2.24N/AN/AN/AN/AN/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
-$91.17MN/A0.00N/AN/AN/AN/AN/A
Semantix, Inc. stock logo
STIX
Semantix
-$63.61M-$0.81N/AN/AN/A-69.49%-45.45%-26.98%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
N/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/AN/AN/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
N/AN/AN/AN/AN/A
Semantix, Inc. stock logo
STIX
Semantix
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
N/A
0.88
0.88
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
1.20
0.41
0.41
Semantix, Inc. stock logo
STIX
Semantix
N/A
1.61
1.61

Institutional Ownership

CompanyInstitutional Ownership
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
3.99%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
81.56%
MMTec, Inc. stock logo
MTC
MMTec
0.25%
Semantix, Inc. stock logo
STIX
Semantix
40.12%

Insider Ownership

CompanyInsider Ownership
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
N/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
9.00%
MMTec, Inc. stock logo
MTC
MMTec
12.80%
Semantix, Inc. stock logo
STIX
Semantix
35.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
XIAO-I Corporation Unsponsored ADR stock logo
AIXI
XIAO-I
28112.46 millionN/ANot Optionable
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
8042.62 million38.79 millionNot Optionable
MMTec, Inc. stock logo
MTC
MMTec
6024.89 million21.71 millionNot Optionable
Semantix, Inc. stock logo
STIX
Semantix
479.10 million51.02 millionNot Optionable

Recent News About These Companies

Semantix, Inc. (STIXF)
Semantix Announces CFO Resignation and Succession Plan
Semantix Inc Class A
Semantix Inc Class A STIX
Semantix, Inc.: Semantix Announces 3Q 2023 Financial Results
Semantix Announces 3Q 2023 Financial Results
Earnings Preview For Semantix
What's in the Cards for Semantix, Inc.'s (STIX) Q3 Earnings?
Pick Up Stix at Excalibur

New MarketBeat Followers Over Time

Media Sentiment Over Time

XIAO-I stock logo

XIAO-I NASDAQ:AIXI

$2.04 +0.22 (+11.81%)
As of 11:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Xiao-I Corporation, through its subsidiary, Shanghai Xiao-i Robot Technology Co., Ltd., provides software services in the People's Republic of China. It offers conversational AI platform that uses deep learning, data enhancement, active learning technologies for dialog management, context processing mechanisms, and driven by a learning system; knowledge fusion platform which integrates Q&A, documents, multimedia, information forms, business processes, knowledge graphs, and multimodal; intelligence voice platform to enhance intelligent speech solutions, realizing the macro processes of intelligent IVP, intelligent outbound calls, speech analysis, agent assistance, and human-computer interaction; and hyperautomation platform that integrates technologies, such as OCR, NLP, and visualized data mining and analysis that enables users to realize business and process automation. The company also provides data intelligence platform which integrates data assets, manages the entire life cycle of data that realizes the entire cycles of data integration, processing, transformation, analysis, and mining; cloud platform that integrates NLP, speech recognition, image recognition, and data analysis capabilities; and intelligent construction support platform which offers parsing, reconstruction, visualization, and multi-dimensional analysis of construction drawings. In addition, it offers vision analysis platform that uses various computer vision-related technologies to apply OCR, detection, video, and image analysis; intelligent hardware support platform which provides the framework of signal collection, processing, analysis, prediction, and others; and metaverse platform that develops virtual digital human. It serves its products to large and medium-sized contact centers, financial institutions, communication operators, government services, industrial manufacturing, medical care, and others. The company was incorporated in 2018 and is based in Shanghai, China.

Kaleido Biosciences stock logo

Kaleido Biosciences NASDAQ:KLDO

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

MMTec stock logo

MMTec NASDAQ:MTC

$0.92 +0.04 (+5.00%)
As of 11:40 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MMTec, Inc., together with its subsidiaries, develops and deploys platforms that enable financial institutions to engage in securities market transactions and settlements worldwide. The company operates in two segments, Gujia and MM Global. It offers Internet-based securities solutions comprising Securities Dealers Trading System, which supports securities registration and clearing, account management, risk management, trading and execution, and third party access middleware; Private Fund Investment Management System that supports multi-account management, fund valuation, risk management, quantitative trading access, liquidation, and requisition management; and Mobile Transaction Individual Client System and PC Client System for Apple IOS, Android, PC, and Web applications. The company enables its customers to white label its trading interface, as well as select modular functionalities. It serves hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms. MMTec, Inc. was incorporated in 2018 and is headquartered in Sheung Wan, Hong Kong.

Semantix stock logo

Semantix NASDAQ:STIX

Semantix, Inc., together with its subsidiaries, provides end-to-end proprietary Software as a Service (SaaS) data platform in Latin America and the United States. The company offers SDP, a multi-cloud SaaS data platform that provides data integration, data operations, machine learning operations, data governance, data sharing, and data visualization for financial institutions; healthcare plans operators, health insurance brokers, hospitals, clinics, and imaging and diagnostics facilities; and retailers. It also sells third-party software licenses to the finance, retail, telecommunications, healthcare, industrials, and other sectors. In addition, the company offers artificial intelligence and data analytics services, including consulting, cloud monitoring, data integration, data science, and data engineering. The company was founded in 2010 and is based in São Paulo, Brazil.